International Journal of Oncology

Papers
(The TQCC of International Journal of Oncology is 9. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
Triple‑negative breast cancer therapy: Current and future perspectives (Review)197
Anticancer peptide: Physicochemical property, functional aspect and trend in clinical application (Review)179
Mechanisms and management of 3rd‑generation EGFR‑TKI resistance in advanced non‑small cell lung cancer (Review)100
Cutaneous melanoma and the immunotherapy revolution (Review)71
Serine, glycine and one‑carbon metabolism in cancer (Review)69
A multidisciplinary approach remains the best strategy to improve and strengthen the management of ovarian cancer (Review)65
Cancer‑associated fibroblast‑induced M2‑polarized macrophages promote hepatocellular carcinoma progression via the plasminogen activator inhibitor‑1 pathway60
Current molecular and clinical insights into uveal melanoma (Review)50
Artificial intelligence radiogenomics for advancing precision and effectiveness in oncologic care (Review)50
Immune-checkpoint inhibitors from cancer to COVID‑19: A promising avenue for the treatment of patients with COVID‑19 (Review)50
High expression of immune checkpoints is associated with the TIL load, mutation rate and patient survival in colorectal cancer48
Butyrate enhances the efficacy of radiotherapy via FOXO3A in colorectal cancer patient‑derived organoids43
Update on uveal melanoma: Translational research from biology to clinical practice (Review)35
Probiotic‑derived ferrichrome inhibits the growth of refractory pancreatic cancer cells34
Activation of PGK1 under hypoxic conditions promotes glycolysis and increases stem cell‑like properties and the epithelial‑mesenchymal transition in oral squamous cell carcinoma cells via the AKT sign34
N6‑methyladenosine upregulates miR‑181d‑5p in exosomes derived from cancer‑associated fibroblasts to inhibit 5‑FU sensitivity by targeting NCALD in colorectal cancer33
Progress and prospects of biomarkers in�primary liver cancer (Review)33
Human‑made electromagnetic fields: Ion forced‑oscillation and voltage‑gated ion channel dysfunction, oxidative stress and DNA damage (Review)32
Pan‑cancer analysis of transmembrane protease serine 2 and cathepsin L that mediate cellular SARS‑CoV‑2 infection leading to COVID-1932
Curcumin inhibits the cancer‑associated fibroblast‑derived chemoresistance of gastric cancer through the suppression of the JAK/STAT3 signaling pathway28
‘Reverse Warburg effect’ of cancer‑associated fibroblasts (Review)27
Effects of curcumin complexes on MDA‑MB‑231 breast cancer cell proliferation27
Signaling pathways and therapeutic approaches in glioblastoma multiforme (Review)27
Riluzole: A neuroprotective drug with potential as a novel anti‑cancer agent (Review)27
Long non‑coding RNA FEZF1‑AS1 facilitates non‑small cell lung cancer progression via the ITGA11/miR‑516b‑5p axis26
Role of taurine, its haloamines and its lncRNA TUG1 in both inflammation and cancer progression. On the road to therapeutics? (Review)26
Doxorubicin and CD‑CUR inclusion complex co‑loaded in thermosensitive hydrogel PLGA‑PEG‑PLGA localized administration for osteosarcoma26
Critical role of mTOR in regulating aerobic glycolysis in carcinogenesis (Review)25
NUPR1 and its potential role in cancer and pathological conditions (Review)25
Role of macrophages in tumor progression and therapy (Review)24
Characterization of KIF20A as a prognostic biomarker and therapeutic target for different subtypes of breast cancer24
Long non‑coding RNA nuclear paraspeckle assembly transcript 1 regulates ionizing radiation‑induced pyroptosis via microRNA‑448/gasdermin E in colorectal cancer cells24
GBP1 promotes erlotinib resistance via PGK1‑activated EMT signaling in non‑small cell lung cancer24
Regulatory effect of the MAFG‑AS1/miR‑150‑5p/MYB axis on the proliferation and migration of breast cancer cells23
Protective effects of combined treatment with mild hypothermia and edaravone against cerebral ischemia/reperfusion injury via oxidative stress and Nrf2 pathway regulation22
Underlying metastasis mechanism and clinical application of exosomal circular RNA in tumors (Review)22
Exosomal transfer of miR‑25‑3p promotes the proliferation and temozolomide resistance of glioblastoma cells by targeting FBXW721
DNA methylation and breast cancer: A way forward (Review)21
MUC1 is an oncoprotein with a significant role in apoptosis (Review)21
Sequestosome 1/p62: A multitasker in the regulation of malignant tumor aggression (Review)21
Roles of exosomes in cancer chemotherapy resistance, progression, metastasis and immunity, and their clinical applications (Review)20
Collagen type VI‑α1 and 2 repress the proliferation, migration and invasion of bladder cancer cells20
Association of the microbiome with colorectal cancer development (Review)20
Novel PI3K/Akt/mTOR signaling inhibitor, W922, prevents colorectal cancer growth via the regulation of autophagy20
Isoorientin induces the apoptosis and cell cycle arrest of A549 human lung cancer cells via the ROS‑regulated MAPK, STAT3 and NF‑κB signaling pathways19
The TLR4/ERK/PD‑L1 axis may contribute to NSCLC initiation18
Role of Nectin‑4 protein in cancer (Review)18
Clinical crosstalk between microRNAs and gastric cancer (Review)18
miR‑508‑3p suppresses the development of ovarian carcinoma by targeting CCNA2 and MMP718
Emerging roles and mechanisms of microRNA‑222‑3p in human cancer (Review)18
Immunological potential of tertiary lymphoid structures surrounding the primary tumor in gastric cancer18
SMYD3 overexpression indicates poor prognosis and promotes cell proliferation, migration and invasion in non‑small cell lung cancer18
Biomarkers of tumor invasiveness in proteomics (Review)17
lncRNA cytoskeleton regulator reduces non‑small cell lung cancer radiosensitivity by downregulating miRNA‑206 and activating prothymosin α17
Crosstalk between YAP and TGFβ regulates SERPINE1 expression in mesenchymal lung cancer cells17
Identification of the most common BRCA alterations through analysis of germline mutation databases: Is droplet digital PCR an additional strategy for the assessment of such alterations in breast and o17
MicroRNA‑103a‑3p promotes metastasis by targeting TPD52 in salivary adenoid cystic carcinoma17
Novel circRNA_0071196/miRNA‑19b‑3p/CIT axis is associated with proliferation and migration of bladder cancer17
[Erratum] circRNA_001275 upregulates Wnt7a expression by competitively sponging miR‑370‑3p to promote cisplatin resistance in esophageal cancer17
Novel insights on gut microbiota manipulation and immune checkpoint inhibition in cancer (Review)17
CircRNA hsa_circ_0070934 functions as a competitive endogenous RNA to regulate HOXB7 expression by sponging miR‑1236‑3p in cutaneous squamous cell carcinoma17
TGF‑β inhibitor RepSox suppresses osteosarcoma via the JNK/Smad3 signaling pathway16
Ribosome 18S m6A methyltransferase METTL5 promotes pancreatic cancer progression by modulating c‑Myc translation16
Overall survival in stage IV EGFR mutation‑positive NSCLC: Comparing first‑, second‑ and third‑generation EGFR‑TKIs (Review)16
Research status and prospects of biomarkers for nasopharyngeal carcinoma in the era of high‑throughput omics (Review)16
PLOD2-driven IL-6/STAT3 signaling promotes the invasion and metastasis of oral squamous cell carcinoma via activation of integrin β116
Neural stem cell‑derived exosomes transfer miR‑124‑3p into cells to inhibit glioma growth by targeting FLOT216
Interleukin‑8 released by cancer‑associated fibroblasts attenuates the autophagy and promotes the migration of ovarian cancer cells16
CYP11A1‑derived vitamin D hydroxyderivatives as candidates for therapy of basal and squamous cell carcinomas16
WBSCR22 and TRMT112 synergistically suppress cell proliferation, invasion and tumorigenesis in pancreatic cancer via transcriptional regulation of ISG1516
Effects of PI3K and FGFR inhibitors alone and in combination, and with/without cytostatics in childhood neuroblastoma cell lines15
Exosomes released by imatinib‑resistant K562 cells contain specific membrane markers, IFITM3, CD146 and CD36 and increase the survival of imatinib‑sensitive cells in the presence of imatinib15
Genomic characterization of five commonly used endometrial cancer cell lines15
Metformin impairs cisplatin resistance effects in A549 lung cancer cells through mTOR signaling and other metabolic pathways15
Everolimus therapy and side‑effects: A systematic review and meta‑analysis15
Circular RNA is a popular molecule in tumors of the digestive system (Review)15
circUBAP2 regulates osteosarcoma progression via the miR‑204‑3p/HMGA2 axis15
Chitinase 3-like 1 secreted from cancer-associated fibroblasts promotes tumor angiogenesis via interleukin-8 secretion in colorectal cancer15
Targeting cancer stem cells in cholangiocarcinoma (Review)14
Resveratrol modulates the apoptosis and autophagic death of human lung adenocarcinoma A549 cells via a p53‑dependent pathway: Integrated bioinformatics analysis and experimental validation14
Correlation of SARS‑CoV‑2 to cancer: Carcinogenic or anticancer? (Review)14
Stromal cells in the tumor microenvironment promote the progression of oral squamous cell carcinoma14
Elevation of ADAM12 facilitates tumor progression by enhancing metastasis and immune infiltration in gastric cancer14
Lactoferrin may inhibit the development of cancer via its immunostimulatory and immunomodulatory activities14
Diagnosis, prognosis and treatment of primary central nervous system lymphoma in the elderly population (Review)14
Silencing IDO2 in dendritic cells: A novel strategy to strengthen cancer immunotherapy in a murine lung cancer model14
Activin A triggers angiogenesis via regulation of VEGFA and its overexpression is associated with poor prognosis of oral squamous cell carcinoma14
Increased expression of PSME2 is associated with clear cell renal cell carcinoma invasion by regulating BNIP3‑mediated autophagy13
Epigenetic modification regulates tumor progression and metastasis through EMT (Review)13
Epigallocatechin‑3‑gallate hinders metabolic coupling to suppress colorectal cancer malignancy through targeting aerobic glycolysis in cancer‑associated fibroblasts13
lncRNA SNHG22 sponges miR‑128‑3p to promote the progression of colorectal cancer by upregulating E2F313
MicroRNA‑137 regulates hypoxia‑mediated migration and epithelial‑mesenchymal transition in prostate cancer by targeting LGR4 via the EGFR/ERK signaling pathway13
Cholesterol metabolism in drug‑resistant cancer (Review)13
Lumican mediates HTB94 chondrosarcoma cell growth via an IGF‑IR/Erk1/2 axis13
Three‑dimensional models to study breast cancer (Review)13
Macrolide antibiotics enhance the antitumor effect of lansoprazole resulting in lysosomal membrane permeabilization‑associated cell death13
Cutaneous melanoma dissemination is dependent on the malignant cell properties and factors of intercellular crosstalk in the cancer microenvironment (Review)13
Menin‑MLL inhibitors induce ferroptosis and enhance the anti‑proliferative activity of auranofin in several types of cancer cells12
SEPT6 drives hepatocellular carcinoma cell proliferation, migration and invasion via the Hippo/YAP signaling pathway12
Potential of the tumor‑derived extracellular vesicles carrying the miR‑125b‑5p target TNFAIP3 in reducing the sensitivity of diffuse large B cell lymphoma to rituximab12
The TLR7/8 agonist R848 optimizes host and tumor immunity to improve therapeutic efficacy in murine lung cancer12
Shikonin suppresses colon cancer cell growth and exerts synergistic effects by regulating ADAM17 and the IL‑6/STAT3 signaling pathway12
lncRNA ST3GAL6‑AS1 promotes invasion by inhibiting hnRNPA2B1‑mediated ST3GAL6 expression in multiple myeloma12
Exosomal proteins: Key players mediating pre‑metastatic niche formation and clinical implications (Review)12
FAM83A exerts tumor‑suppressive roles in cervical cancer by regulating integrins12
Cellular metabolism in pancreatic cancer as a tool for prognosis and treatment (Review)12
Isolation and analysis of tumor‑derived extracellular vesicles from head and neck squamous cell carcinoma plasma by galectin‑based glycan recognition particles12
High‑throughput screening identification of a small‑molecule compound that induces ferroptosis and attenuates the invasion and migration of hepatocellular carcinoma cells by targeting the STAT3/GPX4 a12
Noggin is associated with a poor prognosis of gastric cancer by promoting the proliferation of gastric cancer cells via the upregulation of EGFR12
Parthenolide inhibits the tumor characteristics of renal cell carcinoma12
circ‑LRP6 contributes to osteosarcoma progression by regulating the miR‑141‑3p/HDAC4/HMGB1 axis11
Doxorubicin selectively induces apoptosis through the inhibition of a novel isoform of Bcl‑2 in acute myeloid leukaemia MOLM‑13 cells with reduced Beclin 1 expression11
Hypoplastic myelodysplastic syndrome and acquired aplastic anemia: Immune‑mediated bone marrow failure syndromes (Review)11
Circadian clock as a possible control point in colorectal cancer progression (Review)11
NcRNAs: Multi‑angle participation in the regulation of glioma chemotherapy resistance (Review)11
Downregulation of METTL6 mitigates cell progression, migration, invasion and adhesion in hepatocellular carcinoma by inhibiting cell adhesion molecules11
Digitoxin inhibits HeLa cell growth through the induction of G2/M cell cycle arrest and apoptosis in vitro and in vivo11
LncCCAT1 interaction protein PKM2 upregulates SREBP2 phosphorylation to promote osteosarcoma tumorigenesis by enhancing the Warburg effect and lipogenesis11
Targeting the mTOR pathway using novel ATP‑competitive inhibitors, Torin1, Torin2 and XL388, in the treatment of glioblastoma11
Glioma cells are resistant to inflammation‑induced alterations of mitochondrial dynamics11
METTL3 antagonizes 5‑FU chemotherapy and confers drug resistance in colorectal carcinoma11
New insights into the management of differentiated thyroid carcinoma in children and adolescents (Review)11
Roles of small extracellular vesicles in the development, diagnosis and possible treatment strategies for hepatocellular carcinoma (Review)10
DYRK1A suppression attenuates HIF‑1α accumulation and enhances the anti‑liver cancer effects of regorafenib and sorafenib under hypoxic conditions10
MicroRNA‑301a/ZNRF3/wnt/β‑catenin signal regulatory crosstalk mediates glioma progression10
Immunological modulation of the Th1/Th2 shift by ionizing radiation in tumors (Review)10
LINC00514 promotes lipogenesis and tumor progression in esophageal squamous cell carcinoma by sponging miR‑378a‑5p to enhance SPHK1 expression10
Dexamethasone inhibits stemness maintenance and enhances chemosensitivity of hepatocellular carcinoma stem cells by inducing deSUMOylation of HIF‑1α and Oct410
Inhibiting the NF-κB pathway enhances the antitumor effect of cabazitaxel by downregulating Bcl-2 in pancreatic cancer10
Proteomics and functional study reveal marginal zone B and B1 cell specific protein as a candidate marker of multiple myeloma10
The long non‑coding RNA CASC7 inhibits growth and invasion of non‑small cell lung cancer cells through phosphatase and tensin homolog upregulation via sequestration of miR‑92a10
lncRNA HCP5 acts as a ceRNA to regulate EZH2 by sponging miR‑138‑5p in cutaneous squamous cell carcinoma10
Long non‑coding RNA LUCAT1 contributes to cisplatin resistance by regulating the miR‑514a‑3p/ULK1 axis in human non‑small cell lung cancer10
TRIM35 ubiquitination regulates the expression of PKM2 tetramer and dimer and affects the malignant behaviour of breast cancer by regulating the Warburg effect10
Upregulation of miRNA‑301a‑3p promotes tumor progression in gastric cancer by suppressing NKRF and activating NF‑κB signaling10
Cyclovirobuxine D inhibits colorectal cancer tumorigenesis via the CTHRC1‑AKT/ERK‑Snail signaling pathway10
Potential of antiviral drug oseltamivir for the treatment of liver cancer10
Efficacy of birinapant in combination with carboplatin in targeting platinum‑resistant epithelial ovarian cancers10
Roles of Rho‑associated kinase in lung cancer (Review)10
Combined inhibition of IL‑6 and IL‑8 pathways suppresses ovarian cancer cell viability and migration and tumor growth10
Inhibitory effects of canagliflozin on pancreatic cancer are mediated via the downregulation of glucose transporter‑1 and lactate dehydrogenase A9
High expression of FUSE binding protein 1 in breast cancer stimulates cell proliferation and diminishes drug sensitivity9
CXCR4 blockade sensitizes osteosarcoma to doxorubicin by inducing autophagic cell death via PI3K‑Akt‑mTOR pathway inhibition9
Recent progress of circular RNAs in different types of human cancer: Technological landscape, clinical opportunities and challenges (Review)9
miR‑383 increases the cisplatin sensitivity of lung adenocarcinoma cells through inhibition of the RBM24‑mediated NF‑κB signaling pathway9
Role of telomere length in human carcinogenesis (Review)9
Blocking the Wnt/β‑catenin signaling pathway to treat colorectal cancer: Strategies to improve current therapies (Review)9
Knockdown of TMED3 inhibits cell viability and migration and increases apoptosis in human chordoma cells9
Long non‑coding RNA 01614 hyperactivates WNT/β‑catenin signaling to promote pancreatic cancer progression by suppressing GSK‑3β9
Cisplatin enhances protein O‑GlcNAcylation by altering the activity of OGT, OGA and AMPK in human non‑small cell lung cancer cells9
Galectin‑1 binds GRP78 to promote the proliferation and metastasis of gastric cancer9
Matrix metalloproteinase‑1 expression is regulated by HIF‑1‑dependent and epigenetic mechanisms and serves a tumor‑suppressive role in gastric cancer progression9
Doramectin inhibits glioblastoma cell survival via regulation of autophagy in vitro and in vivo9
Glioma‑neuronal interactions in tumor progression: Mechanism, therapeutic strategies and perspectives (Review)9
0.053563117980957